Table 1.
Day 18 in vivo drug synergy
| SF ratio* | 1.46 |
| Synergy (%) | 46 |
| T-statistic | 1.86 |
| One-sided p value | 0.038 |
*
Ratio of surviving fraction under Bliss independence to surviving fraction of the capmatinib/merestinib combination on day 18
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.